Drug
Low Dose Budesonide
Low Dose Budesonide: highest development phase Post-Market, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Low Dose Budesonide NCT04314375 | Post-Market | Ulcerative Colitis |
Latest
No recent events.
Follow Low Dose Budesonide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.